Clinical Trial Update: Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating autologous stem cell transplantation for patients with refractory systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Autologous stem cell transplantation (autologous stem cell transplantation)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: UNKNOWN